161 related articles for article (PubMed ID: 29137219)
1. Functional characterization of lysine-specific demethylase 2 (LSD2/KDM1B) in breast cancer progression.
Chen L; Vasilatos SN; Qin Y; Katz TA; Cao C; Wu H; Tasdemir N; Levine KM; Oesterreich S; Davidson NE; Huang Y
Oncotarget; 2017 Oct; 8(47):81737-81753. PubMed ID: 29137219
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of histone demethylase, LSD2 (KDM1B), attenuates DNA methylation and increases sensitivity to DNMT inhibitor-induced apoptosis in breast cancer cells.
Katz TA; Vasilatos SN; Harrington E; Oesterreich S; Davidson NE; Huang Y
Breast Cancer Res Treat; 2014 Jul; 146(1):99-108. PubMed ID: 24924415
[TBL] [Abstract][Full Text] [Related]
3. LSD2 Is an Epigenetic Player in Multiple Types of Cancer and Beyond.
Kim HM; Liu Z
Biomolecules; 2024 May; 14(5):. PubMed ID: 38785960
[TBL] [Abstract][Full Text] [Related]
4. The Catalytic-Dependent and -Independent Roles of Lsd1 and Lsd2 Lysine Demethylases in Heterochromatin Formation in
Marayati BF; Tucker JF; Cerda DA; Hou TC; Chen R; Sugiyama T; Pease JB; Zhang K
Cells; 2020 Apr; 9(4):. PubMed ID: 32295063
[TBL] [Abstract][Full Text] [Related]
5. Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression.
Cao C; Vasilatos SN; Bhargava R; Fine JL; Oesterreich S; Davidson NE; Huang Y
Oncogene; 2017 Jan; 36(1):133-145. PubMed ID: 27212032
[TBL] [Abstract][Full Text] [Related]
6. Human LSD2/KDM1b/AOF1 regulates gene transcription by modulating intragenic H3K4me2 methylation.
Fang R; Barbera AJ; Xu Y; Rutenberg M; Leonor T; Bi Q; Lan F; Mei P; Yuan GC; Lian C; Peng J; Cheng D; Sui G; Kaiser UB; Shi Y; Shi YG
Mol Cell; 2010 Jul; 39(2):222-33. PubMed ID: 20670891
[TBL] [Abstract][Full Text] [Related]
7. Regulation of tissue factor pathway inhibitor-2 (TFPI-2) expression by lysine-specific demethylase 1 and 2 (LSD1 and LSD2).
Mino K; Nishimura S; Ninomiya S; Tujii H; Matsumori Y; Tsuchida M; Hosoi M; Koseki K; Wada S; Hasegawa M; Sasaki R; Murakami-Yamaguchi Y; Narita H; Suzuki T; Miyata N; Mizukami T
Biosci Biotechnol Biochem; 2014; 78(6):1010-7. PubMed ID: 25036127
[TBL] [Abstract][Full Text] [Related]
8. Lysine-specific histone demethylase 1B (LSD2/KDM1B) represses p53 expression to promote proliferation and inhibit apoptosis in colorectal cancer through LSD2-mediated H3K4me2 demethylation.
Cai S; Wang J; Zeng W; Cheng X; Liu L; Li W
Aging (Albany NY); 2020 Jul; 12(14):14990-15001. PubMed ID: 32726297
[TBL] [Abstract][Full Text] [Related]
9. Investigating the role of LSD2 as an epigenetic regulator in Ewing sarcoma.
Patel PO; Pishas KI; Taslim C; Selich-Anderson J; Theisen ER; Lessnick SL
Oncotarget; 2019 Jun; 10(39):3865-3878. PubMed ID: 31231465
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of KDM1B inhibits cell proliferation and induces apoptosis of pancreatic cancer cells.
Wang Y; Sun L; Luo Y; He S
Pathol Res Pract; 2019 May; 215(5):1054-1060. PubMed ID: 30846414
[TBL] [Abstract][Full Text] [Related]
11. Lysine‑specific demethylase 2 contributes to the proliferation of small cell lung cancer by regulating the expression of TFPI‑2.
Cao Y; Guo C; Yin Y; Li X; Zhou L
Mol Med Rep; 2018 Jul; 18(1):733-740. PubMed ID: 29845195
[TBL] [Abstract][Full Text] [Related]
12. The Role of LSD1 and LSD2 in Cancers of the Gastrointestinal System: An Update.
Malagraba G; Yarmohammadi M; Javed A; Barceló C; Rubio-Tomás T
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327654
[TBL] [Abstract][Full Text] [Related]
13. Structure-function analysis reveals a novel mechanism for regulation of histone demethylase LSD2/AOF1/KDM1b.
Zhang Q; Qi S; Xu M; Yu L; Tao Y; Deng Z; Wu W; Li J; Chen Z; Wong J
Cell Res; 2013 Feb; 23(2):225-41. PubMed ID: 23266887
[TBL] [Abstract][Full Text] [Related]
14. Histone demethylase LSD2 acts as an E3 ubiquitin ligase and inhibits cancer cell growth through promoting proteasomal degradation of OGT.
Yang Y; Yin X; Yang H; Xu Y
Mol Cell; 2015 Apr; 58(1):47-59. PubMed ID: 25773598
[TBL] [Abstract][Full Text] [Related]
15. ITIH5 mediates epigenetic reprogramming of breast cancer cells.
Rose M; Kloten V; Noetzel E; Gola L; Ehling J; Heide T; Meurer SK; Gaiko-Shcherbak A; Sechi AS; Huth S; Weiskirchen R; Klaas O; Antonopoulos W; Lin Q; Wagner W; Veeck J; Gremse F; Steitz J; Knüchel R; Dahl E
Mol Cancer; 2017 Feb; 16(1):44. PubMed ID: 28231808
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of phenylcyclopropylamine compounds by enzymatic assay of lysine-specific demethylase 2 in the presence of NPAC peptide.
Kakizawa T; Mizukami T; Itoh Y; Hasegawa M; Sasaki R; Suzuki T
Bioorg Med Chem Lett; 2016 Feb; 26(4):1193-5. PubMed ID: 26794039
[TBL] [Abstract][Full Text] [Related]
17. The NPAC-LSD2 complex in nucleosome demethylation.
Caroli J; Mattevi A
Enzymes; 2023; 53():97-111. PubMed ID: 37748839
[TBL] [Abstract][Full Text] [Related]
18. LSD2/KDM1B and its cofactor NPAC/GLYR1 endow a structural and molecular model for regulation of H3K4 demethylation.
Fang R; Chen F; Dong Z; Hu D; Barbera AJ; Clark EA; Fang J; Yang Y; Mei P; Rutenberg M; Li Z; Zhang Y; Xu Y; Yang H; Wang P; Simon MD; Zhou Q; Li J; Marynick MP; Li X; Lu H; Kaiser UB; Kingston RE; Xu Y; Shi YG
Mol Cell; 2013 Feb; 49(3):558-70. PubMed ID: 23260659
[TBL] [Abstract][Full Text] [Related]
19. Structure-Activity Relationship and
Niwa H; Watanabe C; Sato S; Harada T; Watanabe H; Tabusa R; Fukasawa S; Shiobara A; Hashimoto T; Ohno O; Nakamura K; Tsuganezawa K; Tanaka A; Shirouzu M; Honma T; Matsuno K; Umehara T
ACS Med Chem Lett; 2022 Sep; 13(9):1485-1492. PubMed ID: 36105323
[No Abstract] [Full Text] [Related]
20. Lysine-specific demethylase 2 suppresses lipid influx and metabolism in hepatic cells.
Nagaoka K; Hino S; Sakamoto A; Anan K; Takase R; Umehara T; Yokoyama S; Sasaki Y; Nakao M
Mol Cell Biol; 2015 Apr; 35(7):1068-80. PubMed ID: 25624347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
